Prescription GLP-1 receptor agonists such as semaglutide and tirzepatide have undergone extensive clinical trials and received FDA approval for specific indications
Rajesh Sharma, Mohsen Abbasi-Kangevari, Rami Abd-Rabu
Dutka M, Bobiski R, Francuz T, et al
Using recommended doses minimizes risks
[12][13][14][15][16][17][18][19][20][21] The reasons for the low utilization of metformin among individuals with prediabetes are not fully understood but have been postulated to include inconsistencies among clinical guidelines, limited evidence regarding its long-term efficacy in preventing T2DM and its macrovascular and microvascular complications
Histological sections showed two cellular components, the first consisting of epithelial cells with abundant pigmented cytoplasm and the other component were immature, small, bluish, round cells with hyperchromatic nuclei and sparse cytoplasm